Berlin – A significant investment is poised to reshape access to mental healthcare. Grow Therapy, a rapidly expanding platform connecting patients with therapists, has secured $150 million in Series D funding, bringing its total capital raised to $328 million and establishing a reported $3 billion valuation. The funding round was led by TCV and Goldman Sachs Alternatives, with participation from BCI and Menlo Ventures. This infusion of capital will fuel the company’s expansion into enterprise partnerships, aiming to address systemic barriers to consistent mental healthcare access.
Grow Therapy’s growth has been remarkable. The company reports a $1 billion revenue run rate and facilitated 7 million therapy visits in 2025 alone, connecting a network of 26,000 providers with patients through over 125 health insurer partnerships. This scale positions Grow Therapy as a major player in a mental healthcare landscape increasingly reliant on telehealth and digital solutions.
Addressing the “EAP Cliff” with Seamless Continuity of Care
A central focus of Grow Therapy’s expansion is tackling the well-documented shortcomings of traditional Employee Assistance Programs (EAPs). For decades, EAPs have offered a limited number of free therapy sessions – typically three to five – to employees. However, these programs often operate in isolation from an employee’s regular health insurance network. This creates what’s known as the “EAP cliff,” where individuals abruptly lose access to affordable care once their allotted sessions are exhausted, forcing them to either pay significantly higher out-of-pocket rates or start the process of finding a new therapist all over again. This disruption can be particularly damaging for individuals engaged in ongoing treatment for mental health conditions.
Grow Therapy’s redesigned benefit program aims to eliminate this cliff. Beginning in March 2026, companies partnering with Grow Therapy will be able to offer a seamless transition for employees from their EAP sessions to their standard health insurance coverage, allowing them to continue seeing the same therapist without interruption. This represents made possible by Grow Therapy’s extensive integrations with over 125 health insurers, covering approximately 220 million lives, including those enrolled in Medicare and Medicaid. The company is also adopting a pricing model that charges employers only for the care actually delivered, moving away from the flat Per-Member-Per-Month (PMPM) fees common in traditional digital health contracts, which can incentivize providers to over-deliver services regardless of individual patient needs.
Reducing Administrative Burden for Therapists with AI-Powered Tools
The mental health field is facing a critical shortage of providers, and administrative tasks contribute significantly to burnout among those in practice. Recognizing this challenge, Grow Therapy has developed a free, clinically-guided AI notetaker integrated into its Electronic Health Record (EHR) software. This tool utilizes ambient listening to capture therapy sessions and automatically structure clinical documentation, reportedly reducing provider documentation time by nearly 70%. According to the company, this not only streamlines workflows but also improves the accuracy of documentation compared to manual note-taking. The increased efficiency allows therapists to see more patients, with 80% of clients reporting measurable symptom improvement within 30 days, and has contributed to a Net Promoter Score (NPS) of 85, indicating high levels of client satisfaction.
Bridging the Gap Between Primary Care and Mental Health Services
Despite increasing awareness of mental health, a significant gap remains between identification of mental health needs in primary care settings and actual access to treatment. More than 70% of individuals receive a mental health screening during a routine medical visit, yet less than half ultimately connect with mental healthcare services. Grow Therapy is addressing this issue by extending its platform directly into health systems, beginning with a partnership with Circle Medical. This integration allows primary care teams to coordinate referrals, share clinical context (with patient consent), and schedule initial therapy sessions directly within existing workflows, streamlining the process and reducing barriers to care.
Key Takeaways
- Significant Funding: Grow Therapy’s $150 million Series D round underscores the growing investor confidence in digital mental health solutions.
- Addressing Access Barriers: The company’s focus on eliminating the “EAP cliff” and streamlining referrals from primary care aims to improve access to consistent mental healthcare.
- Provider Support: AI-powered tools designed to reduce administrative burden are crucial for attracting and retaining therapists in a challenging labor market.
- Enterprise Expansion: Grow Therapy’s move into enterprise partnerships signals a broader strategy to integrate mental healthcare into existing benefit structures.
The success of Grow Therapy’s model will depend on its ability to navigate the complexities of healthcare reimbursement, maintain data privacy and security, and demonstrate measurable improvements in patient outcomes. The company’s continued integration with health systems and insurers will be critical to its long-term sustainability. Further developments regarding the rollout of the redesigned EAP program and the expansion of its AI-powered tools are expected throughout 2026.
What are your thoughts on the role of technology in expanding access to mental healthcare? Share your comments below, and please share this article with your network.
Related reading